Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

Contact Us:

Questions or suggestions? Please fill out the form below. Your information will not be shared or used for any other purpose.

First Name
Last Name
Organization
Address 1
Address 2
City
State
Zip Code
Email
Phone 1
Phone 2
Subject
Comments

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

No More Free Rx Samples
Carolinas HealthCare System leads the way Carolina Observer

---

Glaxo 'Downplayed' Warning
Abacavir doubles MI risk Independent

---

Physician, Reveal Thyself
Heart stent studies don't disclose funding Businessweek (PLoS One study)

---

Protecting Human Subjects
US clinical trials no longer required Center for Science in the Public

---

FDA Slow To Issue DTCA Warnings
Ads discontinued before letters received Pharmalot (read GAO report)

---

Celebrex Doesn't Prevent Memory Loss
Nor does naproxen Bloomberg (Archives of Neurology study)

---

Pfizer to Disclose Grants
With Lilly, supports revised Sunshine Act Pharmatimes

---

Migraine Medicines Problematic
Associated with serotonin syndrome Bloomberg (NEJM study)

---

Stealth Marketers
Shilling for pharma on NPR Slate

---

Psychiatry Handbook Linked to Drug Industry
COIs in over half of new working group members NYT (read Center for Science in the Public Interest article)

---

Legislators: Glaxo Letter on Gift Ban May Backfire
Does MA have a “strong anti-biopharmaceutical streak?” Boston Herald (read additional article)

---

Glaxo Tries to Corner Weight Loss Market
Tells FDA to deny dietary supplement claims Pharmalot

---

Commentary

Prescription Tracking and Public Health
AMA’s PDRP inadequate JGIM

---

Click HERE to read the entire news archives